CLRB Company Profile and Key Details

Q: Who are the executives of CLRB?

Mr. Jarrod LongcorChief Operating OfficerMr. Darrell Shane LeaChief Commercial OfficerMr. Shane LeaChief Commercial OfficerMr. Andrei Shustov M.D.Senior Vice President of MedicalMr. James V. CarusoPres, Chief Executive Officer & DirectorMr. Chad J. Kolean C.P.A., CPAVice President, Chief Financial Officer & Sec.Dr. Andrei Shustov M.D.Senior Vice President of MedicalMr. Chad J. Kolean CPA, CPAVice President, Chief Financial Officer & Sec.

NASDAQ : CLRB

Cellectar Biosciences

$2.31

-0.06-2.53%

Open: 4:00 PM

63.16

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Cellectar Biosciences, Inc. (CLRB) stock declined over -2.53%, trading at $2.31 on NASDAQ, down from the previous close of $2.37. The stock opened at $2.39, fluctuating between $2.31 and $2.39 in the recent session.

Stock Snapshot

2.37

Prev. Close

18.46M

Market Cap

2.31

Day Low

-0.35

P/E Ratio

-6.66

EPS (TTM)

-1.79

Cash Flow per Share

2.39

Open

7.99M

Number of Shares

2.385

Day High

94.33%

Free Float in %

-0.07

Book Value

38.2K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 11, 2026	2.35	2.40	2.31	2.31	38.2K
Sep 10, 2026	2.35	2.40	2.35	2.37	18.59K
Sep 09, 2026	2.41	2.45	2.35	2.37	44.37K
Sep 08, 2026	2.46	2.47	2.38	2.41	27.55K
Sep 04, 2026	2.33	2.40	2.33	2.37	26.57K
Sep 03, 2026	2.39	2.44	2.34	2.35	69.49K
Sep 02, 2026	2.46	2.50	2.42	2.43	48.76K
Sep 01, 2026	2.48	2.54	2.45	2.46	46.42K
Aug 31, 2026	2.52	2.55	2.49	2.51	17.29K
Aug 28, 2026	2.55	2.55	2.51	2.53	23.83K
Aug 27, 2026	2.57	2.57	2.52	2.54	10.31K
Aug 26, 2026	2.46	2.59	2.46	2.54	13.2K
Aug 25, 2026	2.59	2.60	2.50	2.54	16.66K
Aug 24, 2026	2.56	2.59	2.50	2.52	23.17K
Aug 21, 2026	2.60	2.60	2.50	2.59	26.65K
Aug 20, 2026	2.62	2.62	2.50	2.59	32.8K
Aug 19, 2026	2.61	2.70	2.61	2.62	56.23K
Aug 18, 2026	2.51	2.60	2.51	2.59	31.33K
Aug 17, 2026	2.63	2.66	2.56	2.56	51.05K
Aug 14, 2026	2.50	2.64	2.50	2.60	46.57K

Contact Details

Florham Park, NJ 07932

United States

https://www.cellectar.com 608 441 8120

About Company

Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies. Additionally, CLR 131 is being studied in Phase 2B for r/r multiple myeloma (MM) and in Phase I trials targeting a range of pediatric cancers, r/r head and neck cancers, and R/R MM. Furthermore, Cellectar is advancing CLR 1900, another PDC-based chemotherapeutic program, which is in preclinical stages with the aim of treating solid tumors. The firm also participates in collaborative PDC development initiatives with partners such as Avicenna Oncology GMBH for the CLR 2000 Series, Orano Med for the CLR 12120 Series, as well as IntoCell Inc. and LegoChemBio. Established in 2002, Cellectar Biosciences maintains its corporate headquarters in Florham Park, New Jersey.

Stock Peers

ARGX

0.35+0.04%

argenx SE$984.39 REGN

-11.77-1.48%

Regeneron Pharmaceuticals, Inc.$781.49 MDGL

1.37+0.26%

Madrigal Pharmaceuticals, Inc.$534.49 VRTX

0.88+0.17%

Vertex Pharmaceuticals Incorporated$515.44 UTHR

-6.75-1.34%

United Therapeutics Corporation$497.11 KRYS

1.45+0.42%

Krystal Biotech, Inc.$347.00 ONC

4.71+1.38%

BeOne Medicines AG$346.51 PRAX

-3.99-1.18%

Praxis Precision Medicines, Inc.$334.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.78-1.65%

Ligand Pharmaceuticals Incorporated$284.47

Frequently Asked Questions

What is the current Cellectar Biosciences, Inc. (CLRB) stock price?

Cellectar Biosciences, Inc. (NASDAQ: CLRB) stock price is $2.31 in the last trading session. During the trading session, CLRB stock reached the peak price of $2.39 while $2.31 was the lowest point it dropped to. The percentage change in CLRB stock occurred in the recent session was -2.53% while the dollar amount for the price change in CLRB stock was - $0.06.

CLRB's industry and sector of operation?

The NASDAQ listed CLRB is part of Biotechnology industry that operates in the broader Healthcare sector. Cellectar Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CLRB?

Mr. Jarrod Longcor
Chief Operating Officer
Mr. Darrell Shane Lea
Chief Commercial Officer
Mr. Shane Lea
Chief Commercial Officer
Mr. Andrei Shustov M.D.
Senior Vice President of Medical
Mr. James V. Caruso
Pres, Chief Executive Officer & Director
Mr. Chad J. Kolean C.P.A., CPA
Vice President, Chief Financial Officer & Sec.
Dr. Andrei Shustov M.D.
Senior Vice President of Medical
Mr. Chad J. Kolean CPA, CPA
Vice President, Chief Financial Officer & Sec.

How CLRB did perform over past 52-week?

CLRB's closing price is 5% higher than its 52-week low of $2.20 where as its distance from 52-week high of $6.52 is -64.57%.

How many employees does CLRB have?

Number of CLRB employees currently stands at 11.

Link for CLRB official website?

Official Website of CLRB is: https://www.cellectar.com

How do I contact CLRB?

CLRB could be contacted at phone 608 441 8120 and can also be accessed through its website. CLRB operates from 100 Campus Drive, Florham Park, NJ 07932, United States.

How many shares of CLRB are traded daily?

CLRB stock volume for the day was 38.2K shares. The average number of CLRB shares traded daily for last 3 months was 72.51K.

What is the market cap of CLRB currently?

The market value of CLRB currently stands at $18.46M with its latest stock price at $2.31 and 7.99M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	11
Beta	0.56
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	11
Beta	0.56
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CLRB Company Profile and Key Details

Cellectar Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook